ZA991641B - Treatment of viral disease in swine. - Google Patents

Treatment of viral disease in swine.

Info

Publication number
ZA991641B
ZA991641B ZA9901641A ZA991641A ZA991641B ZA 991641 B ZA991641 B ZA 991641B ZA 9901641 A ZA9901641 A ZA 9901641A ZA 991641 A ZA991641 A ZA 991641A ZA 991641 B ZA991641 B ZA 991641B
Authority
ZA
South Africa
Prior art keywords
swine
treatment
viral disease
viral
disease
Prior art date
Application number
ZA9901641A
Other languages
English (en)
Inventor
Gregory Alan Armbruster
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA991641B publication Critical patent/ZA991641B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9901641A 1998-03-02 1999-03-01 Treatment of viral disease in swine. ZA991641B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7646698P 1998-03-02 1998-03-02

Publications (1)

Publication Number Publication Date
ZA991641B true ZA991641B (en) 2000-09-01

Family

ID=22132217

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901641A ZA991641B (en) 1998-03-02 1999-03-01 Treatment of viral disease in swine.

Country Status (16)

Country Link
US (1) US6034070A (enExample)
EP (1) EP0948967B1 (enExample)
JP (1) JP4555472B2 (enExample)
AT (1) ATE281173T1 (enExample)
AU (1) AU2979899A (enExample)
CA (1) CA2322327C (enExample)
CO (1) CO5080775A1 (enExample)
DE (1) DE69921530T2 (enExample)
DK (1) DK0948967T3 (enExample)
ES (1) ES2230802T3 (enExample)
MY (1) MY124071A (enExample)
PT (1) PT948967E (enExample)
SI (1) SI0948967T1 (enExample)
TW (1) TW565452B (enExample)
WO (1) WO1999044619A1 (enExample)
ZA (1) ZA991641B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506885B1 (en) * 2001-09-27 2003-01-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
CN1607937A (zh) * 2001-10-19 2005-04-20 爱德士实验室公司 用于药理活性化合物的可控释放的可注射组合物
ATE452896T1 (de) 2002-03-12 2010-01-15 Bristol Myers Squibb Co C3-cyanoepothilonderivate
US7282487B2 (en) * 2004-10-28 2007-10-16 Idexx Laboratories Method for treating bacterial infections in horses or pigs with tilmicosin
WO2008012343A2 (en) 2006-07-28 2008-01-31 Intervet International B.V. Macrolide synthesis process
CN103288904B (zh) * 2013-06-28 2015-07-15 宁夏泰瑞制药股份有限公司 一种磷酸替米考星晶体的制备方法
CN103483406A (zh) * 2013-09-25 2014-01-01 宁夏泰瑞制药股份有限公司 一种磷酸替米考星的制备方法
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69666A (en) * 1982-09-13 1987-10-20 Lilly Co Eli 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
US5574020A (en) * 1989-09-28 1996-11-12 Eli Lilly And Company Tilmicosin formulation
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
DK53595A (da) * 1994-05-13 1995-11-14 Iberica Cyanamid Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner
PT732340E (pt) * 1995-03-14 2004-09-30 Akzo Nobel Nv Expressao de polipeptidos do virus da sindrome reprodutiva e respiratoria porcina na mesma celula

Also Published As

Publication number Publication date
EP0948967B1 (en) 2004-11-03
EP0948967A2 (en) 1999-10-13
JP2002505294A (ja) 2002-02-19
ATE281173T1 (de) 2004-11-15
EP0948967A3 (en) 1999-10-20
CO5080775A1 (es) 2001-09-25
US6034070A (en) 2000-03-07
TW565452B (en) 2003-12-11
DE69921530T2 (de) 2005-10-27
WO1999044619A1 (en) 1999-09-10
JP4555472B2 (ja) 2010-09-29
CA2322327C (en) 2009-12-22
AU2979899A (en) 1999-09-20
CA2322327A1 (en) 1999-09-10
MY124071A (en) 2006-06-30
ES2230802T3 (es) 2005-05-01
SI0948967T1 (en) 2005-06-30
DK0948967T3 (da) 2005-02-14
DE69921530D1 (de) 2004-12-09
PT948967E (pt) 2005-02-28

Similar Documents

Publication Publication Date Title
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
PL341364A1 (en) 4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents
GB0025173D0 (en) Therapeutic agents
GB0005251D0 (en) Therapeutic compounds
EP1001782A4 (en) 5,6-HETEROARYL-DIPYRIDO 2,3- $ i (b): 3 ', 2' - $ i (f)] AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
ATE245641T1 (de) Antivirale pyrimidinderivate
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
WO2002002518A3 (en) Compounds to treat alzheimer's disease
WO2002002520A3 (en) Compounds to treat alzheimer's disease
SE9604786D0 (sv) New compounds
AU1808488A (en) Compounds for the treatment of alzheimer's disease
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
EP0278174A3 (en) Use of fluticasone propionate in the treatment of bowel diseases
ZA967746B (en) Treatment of tinnitus using neuroprotective agents.
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
ZA991641B (en) Treatment of viral disease in swine.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
BR0012921A (pt) Compostos calcilìticos
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
IT8921376V0 (it) Manopola monouso, per l'igiene personale di pazienti in genere.
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
WO1998044913A3 (en) Compositions containing mkc-442 in combination with other antiviral agents
ES2078380T3 (es) Oligofosfatos de accion antiviral.